Karen L. Smith - Director at Skye Bioscience, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
SKYE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Karen L. Smith since 4/22/2024

Holdings reported by Karen L. Smith for Skye Bioscience, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 35K $1.19K $0.02 Feb 24, 2025 Direct Common Stock
Director Stock Option (Right to Buy) 40K Jul 2, 2024 Direct Common Stock

Transactions reported by Karen L. Smith for Skye Bioscience, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.